Literature DB >> 6182006

Substance P antagonists active in vitro and in vivo.

J Mizrahi, E Escher, S Caranikas, P D'orléans-Juste, D Regoli.   

Abstract

[Pro4, Trp7,9]SP-(4-11) and a newly developed compound, [Pro4, Trp7,9,10]SP-(4-11) were shown to be potent antagonists of substance P (SP). They inhibited the hypotensive effect of SP in the anesthetised rats, the vasodilator effect in the rabbit perfused heart and the relaxation induced by SP in dog carotid arteries contracted with noradrenaline. Stimulatory actions of SP in the guinea pig ileum and the guinea pig trachea were also inhibited by the two antagonists, which were shown to be specific for substance P and related peptides in all the pharmacological preparations utilised in the present study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6182006     DOI: 10.1016/0014-2999(82)90561-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  In vivo and in vitro actions of mammalian tachykinins.

Authors:  U Holzer-Petsche; E Schimek; R Amann; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

2.  An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.

Authors:  S J Bailey; R L Featherstone; C C Jordan; I K Morton
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.

Authors:  R L Featherstone; P Fosbraey; I K Morton
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

4.  Involvement of substance P in the excitatory action of GABAA agonists on cholinergic neurons in the guinea-pig ileum.

Authors:  M Tonini; L Onori; C A Rizzi; E Perucca; L Manzo; A Crema
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

5.  Presence of a substance P-like peptide in an acid extract of the intestinal bulb of the carp (Cyprinus carpio).

Authors:  T Kitazawa; H Kondo; K Temma
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

6.  Proceedings of the British Pharmacological Society. Cardiff, 10th-12th April, 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

7.  Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms.

Authors:  K H Buchheit; G Engel; E Mutschler; B Richardson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

8.  Spantide III, a superior tachykinin antagonist with high potency and negligible neurotoxicity.

Authors:  K Folkers; R Hakanson; D M Feng; J C Xu; A Janecka; Z Y Wang
Journal:  Amino Acids       Date:  1993-06       Impact factor: 3.520

9.  Development of a new tachykinin antagonist.

Authors:  R Mathison; P Stofer; F Barja; H Immer
Journal:  Experientia       Date:  1984-01-15

10.  Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat.

Authors:  R Couture; A C Cuello
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.